We investigated the acute effects of gabapentin (GABA) on sleep breathing in older men without sleep apnea. A double-blind, randomized, placebo-controlled cross-over pilot study using a bedtime dose of gabapentin 300 mg was conducted in eight non-obese older men. Research suggests that gabapentin may potentially contribute to the development or worsening of sleep apnea symptoms in some individuals. While the exact mechanism is not fully understood, it is believed that gabapentin can affect the central nervous system and respiratory muscles, leading to disruptions in normal breathing patterns during sleep. Medication-induced central sleep apnea (CSA) is one of the eight categories of causes of CSA but in the absence of awareness and careful history may be misclassified as primary CSA. While opioids are a well-known cause of respiratory depression and CSA, non-opioid medications including sodium oxybat Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database Sleep. 2019 Feb 1;42(2). doi: 10.1093/sleep/zsy242. Understanding how gabapentin may affect sleep patterns is crucial in assessing its impact on sleep apnea symptoms and overall sleep quality. Gabapentin has been shown to influence sleep architecture in several ways. We investigated the acute effects of gabapentin (GABA) on sleep breathing in older men without sleep apnea. A double-blind, randomized, placebo-controlled cross-over pilot study using a bedtime dose of gabapentin 300 mg was conducted in eight non-obese older men. The other trial showed gabapentin alone increased pauses in breathing during sleep. The three observational studies at one academic medical center showed a relationship between gabapentinoids given before surgery and respiratory depression occurring after different kinds of surgeries. In this context, baclofen is linked to sleep apnea syndrome [3, 4], aggravating sleep-disordered breathing by depressing central ventilatory drive and/or increasing upper airway obstruction. We hypothesized that gabapentinoids might be associated with sleep apnea syndrome. We investigated the acute effects of gabapentin (GABA) on sleep breathing in older men without sleep apnea. A double-blind, randomized, placebo-controlled cross-over pilot study using a bedtime dose of gabapentin 300 mg was conducted in eight non-obese older men. Polysomnography measured the effects of the intervention. J Clin Sleep Med 10: 1101-1109. Moore RA, Philip JW, Sheena D, Andrew SC (2014) Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev: CD007938. Marvisi M, Balzarini L, Mancini C, Ramponi S, Marvisi C (2015) Fibromyalgia is frequent in obstructive sleep apnea and responds to CPAP therapy. This study revealed that without consideration of the type of sleep outcomes, gabapentin was significantly superior to placebos for the treatment for sleep disorders secondary to RLS, neuropathic pain, alcohol dependence, hot flashes in menopause, fibromyalgia, phantom limb pain, HIV-associated sensory neuropathies, and bipolar disorder. gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems . in breathing during sleep. The three Here, we review drugs in terms of their possible impact on OSA; drugs which (1) may worsen OSA; (2) are unlikely to have an impact on OSA; (3) those for which data are scarce or contradictory; and (4) drugs with a potentially improving effect. Chronic neuropathic pain (NP) is debilitating and impacts sleep health and quality of life. Treatment with gabapentinoids (GBs) has been shown to reduce pain, but its effects on sleep health have not been systematically evaluated. The objective of this systematic review and meta-analysis was to asse Such medications can impact muscle tone, breathing, and sleep architecture (your normal sleep pattern) and contribute to the development of sleep apnea. This article will discuss the medications that can affect sleep apnea and which ones to avoid to prevent worsening the condition. We hypothesized that gabapentinoids might be associated with sleep apnea syndrome. A recent pilot study reported a higher apnea–hypopnea index with gabapentin, supporting our hypothesis [5]. Some studies have found that gabapentin may increase slow-wave sleep, also known as deep sleep, which is crucial for physical restoration and cognitive function. Additionally, it may reduce sleep fragmentation, leading to fewer nighttime awakenings and improved sleep continuity. Hence, gabapentin worsened sleep breathing acutely compared with placebo. Long-term clinical trials are warranted to elucidate the clinical relevance of these findings for the safety profile of sleep apnea, neither are correlated to me being on gabapentin, and then further Lyrica. I was only taking 100 mg of gabapentin at bedtime when I had my first sleep study and my last one I had already switched to Lyrica ( 5 yrs later)and I’m taking 300 mg three times a day. Everybody’s differen, yours might be associated. Central sleep apnea (CSA) is a potentially serious and under-recognized adverse reaction of opioids, baclofen, valproic acid, sodium oxybate, gabapentin, and ticagrelor. CSA may be associated with impaired sleep quality, insomnia, nonrestorative sleep, impaired quality of life, fatigue, daytime sleepiness, and increased morbidity and mortality
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | |
![]() | |
![]() | ![]() |
![]() | ![]() |